Blended Smoking Cessation Treatment Evaluation of effectiveness of a blended face-to-face and web-based smoking cessation treatment versus treatment as usual (Randomised controlled trial)
Completed
- Conditions
- AddictionTobacco addiction
- Registration Number
- NL-OMON47900
- Lead Sponsor
- Saxion Universtiy of Applied Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 344
Inclusion Criteria
willing to quit smoking,
aged 18 or older,
current daily smoker
able to access internet websites and to receive emails
Exclusion Criteria
not able to read or write Dutch language
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The primary outcome parameter is sustained abstinence at 15 months from the<br /><br>start of the smoking cessation treatment. Abstinence is defined as having<br /><br>salivary cotinine levels < 20ng/mL. Participants with a cotinine-value of ><br /><br>20ng/mL are regarded as smokers as well as participants who are lost to<br /><br>follow-up.</p><br>
- Secondary Outcome Measures
Name Time Method <p>Secondery outcome parameters are:<br /><br><br /><br>Internet Skills<br /><br>Smoking status<br /><br>Nicotine dependence (Fagerström)<br /><br>Smoking history<br /><br>Attitude<br /><br>Self-efficacy<br /><br>Readiness to change<br /><br>Stop Smoking History<br /><br>Social support<br /><br>Alcohol (mis)use<br /><br>Substance (mis)use<br /><br>MAP-HSS + special complaints of smokers<br /><br>DASS21<br /><br>Quality of Life (Euroqol 5D)<br /><br>Middle evaluation of treatment<br /><br>Long term evaluation of treatment<br /><br>Adherence<br /><br>Exhaled CO<br /><br>User experience</p><br>